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Allergic  rhinitis  (AR),  by  deﬁnition,  denotes  an  inﬂamma-
tion  of  the  nasal  mucosa,  mediated  by  IgE,  accompanied  by
symptoms  such  as  nasal  congestion,  local  itching,  sneezing
and  rhinorrhea.1
There  have  been  two  large  studies  assessing  the  preva-
lence  of  AR  in  Brazil.  The  ﬁrst,  through  questionnaires
applied  to  children  and  adolescents,  revealed  that  nasal  and
ocular  symptoms  during  the  previous  year,  but  without  the
presence  of  an  upper  respiratory  infection  were  present  in
approximately  12--15%  of  subjects.  The  second,  also  using
questionnaires,  but  evaluating  all  age  ranges  with  a  diagno-
sis  of  AR,  found  a  prevalence  of  9%.2,3
Interestingly,  these  studies  infer  that  the  nasal  symptoms
are  allergic  in  nature,  since  the  presence  of  the  speciﬁc  IgE
has  not  been  proven,  a  basic  assumption  to  determine  an
allergic  etiology  (see  deﬁnition).
In  1859,  Charles  Harrison  Blackley  applied  pollen  to  his
nasal  mucosa  and  that  triggered  the  symptoms  of  rhinitis.
Thus,  the  nasal  challenge  test  for  the  diagnosis  of  allergic
rhinitis  appeared.4 Other  methods  are  also  used  to  study  this
class  of  antibodies  such  as  the  skin  prick  testing  and  speciﬁc
serum  measurements  (immunoenzymatic  and  immunoﬂuo-
rometric  assays).2
One  of  the  ﬁrst  studies  to  demonstrate  the  production  of
speciﬁc  IgE  in  nasal  secretion  only  was  published  in  1975.
Fourteen  patients  with  clinical  symptoms  suggestive  of  AR
caused  by  dust  mites,  although  with  a  negative  radioaller-
gosorbent  test  (RAST)  were  submitted  to  nasal  challenge
testing  with  this  antigen.  All  patients  had  nasal  symptoms,
which  were  absent  in  the  control  group.5
This  fact  demonstrates  that  there  are  two  phenotypes  of
AR.  One  represents  ‘‘classic’’  patients,  who  exhibit  a  char-
acteristic  clinical  picture,  the  presence  of  positive  systemic
speciﬁc  IgE  in  skin  and  serum  tests,  and  have  a  personal
and  family  history  of  atopy.  The  other  phenotype  contains
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rovocation  test  only  for  the  antigen.  These  individuals  have
hat  is  called  Local  Allergic  Rhinitis  (LAR).6
The  prevalence  of  LAR  is  not  known.  Some  studies  show
hat  over  47%  of  cases  of  noninfectious,  non-allergic  rhinitis
ay  be  a result  of  speciﬁc  IgE  production  restricted  to  the
asal  mucosa.7 Being  an  unknown  phenotype,  it  is  under-
iagnosed  so  one  can  potentially  assume  that  the  prevalence
f  an  allergic  etiology  in  nasal  symptoms  is  much  higher  than
hat  is  currently  proven.
There  is  very  little  in-depth  medical  literature  on  LAR;
owever,  the  questions  of  whether  LAR  represents  a  possible
arly  onset  of  AR  has  been  addressed.  Follow-up  of  adult  and
dolescent  patients  with  LAR  for  5  years  did  not  show  any
ifference  in  the  onset  of  atopy  in  (6.25%)  when  compared
o  controls  (5.2%).8
Patients  with  LAR  have  the  same  classic  symptoms  of
hose  with  AR,  such  as  sneezing,  itching,  nasal  obstruc-
ion  and  rhinorrhea.8 A  study  comparing  patients  with
R  and  LAR  also  showed  that  both  share  a  similar  clini-
al  and  demographic  phenotype.  They  occur  preferentially
n  nonsmokers,  female  individuals  who  exhibit  a  severe
ersistent  clinical  picture,  often  with  conjunctival  and
sthma  symptoms;the  house  dust  mite  (Dermatophagoides
teronyssinus) is  the  main  associated  agent.9
In  addition  to  the  dust  mites,  other  antigens  are  associ-
ted  with  LAR,  such  as  pollens  and  fungi,  causing  symptoms
n  both  children  and  adults.10,11
From  a  pathophysiological  point  of  view,  LAR  is  similar
o  AR.  An  inﬂammatory  inﬁltrate  pattern  with  Th2  (IgE-
ediated  clinical  pictures),  immediate  phase  characterized
y  the  activation  and  release  of  basophil  mediators  and  a
ate  phase  with  eosinophil  attraction  and  activation  can  be
bserved.10
Regarding  therapy,  LAR  patients  respond  well  to
oth  oral  and  topical  medications.  Additionally,  they
lso  show  improvement  with  allergen-speciﬁc  subcuta-
eous  immunotherapy,  similarly  to  patients  with  AR.
 pilot  study  with  20  patients  with  LAR  sensitive  to
rasses  were  submitted  to  allergen-speciﬁc  subcutaneous
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mmunotherapy.  At  the  end  of  the  study,  the  authors
bserved  greater  tolerance  to  the  allergen  and  symptom
eduction,  as  well  as  decreased  use  of  rescue  medication.12
urrently,  double-blind  placebo-controlled  studies  are  being
erformed  with  grass  and  house  dust  mite  antigens.7
The  diagnosis  of  LAR  is  corroborated  by  demonstrating
he  presence  of  the  nasal  speciﬁc  IgE  through  nasal  provoca-
ion  test  with  allergens  or  the  local  synthesis  of  IgE,  without
he  presence  of  systemic  atopy.7 The  nasal  secretion  lavage
s  very  useful  to  assess  cellularity,  presence  of  inﬂamma-
ory  mediators  and  speciﬁc  IgE.7 The  nasal  challenge  testing
ith  allergens  reproduces  the  ‘‘natural’’  allergic  reaction,
emonstrating  the  immediate  and  late  phases,  the  sensitiza-
ion  to  the  allergen  and  its  importance  in  symptom  onset.7
n  clinical  practice,  it  is  considered  the  gold  standard  for
he  diagnosis  of  both  AR  and  LAR;  however,  it  is  not  a  rou-
inely  performed  test,  as  it  is  time-consuming  and  requires
ell-trained  staff.7 Therefore,  the  rapid  development  of  an
nexpensive  method  for  the  determination  of  speciﬁc  IgE
n  nasal  secretion  is  important,  so  we  can  learn  the  true
revalence  of  this  phenotype  and  establish  the  correct  and
ppropriate  diagnosis  and  treatment  in  our  patients.
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